CPRT has enrolled participants into clinical studies for many different health indications, including:
Type 1 Diabetes Mellitus:
-
New formulas of insulin
-
Oral medications (tablets)
-
Portable meters and insulin pumps
-
Paediatric studies
-
Family Screening and Prevention studies
-
Retinopathy
Type 2 Diabetes Mellitus (Phases 2-4):
-
Oral medications (including DPP-4 inhibitors, SGLT 1 and 2 inhibitors)
-
Injectable medications (New insulin formulas, GLP-1 agonists, novel metabolic agents)
-
Implant studies- new delivery systems for registered medications
-
Weight loss studies
-
Nephropathy (mild, moderate and severe)
-
Meter studies
Cardiology:
-
Hypertension
-
Heart Failure (reduced ejection fraction)
Hyperlipidaemia (Phase 2 and 3):
-
Familial Hyperlipidaemia (including apheresis patients)
-
High triglycerides
-
Combined dyslipidaemia
-
Statin-intolerant
Respiratory Health:
-
Chronic Obstructive Pulmonary Disease/Emphysema
-
Asthma
-
Prevention of respiratory infections in over 65 year olds
Dermatology:
-
Eczema
-
Infections
Geriatric population (≥ 65years:)
-
Immune system
-
Healthy aging and general wellbeing
-
Vaccine response
-
Prevention of infections
Long-term Health Outcome Trials assessing Cardiovascular, Renal, or Bone Health Outcomes:
-
Diabetic medications
-
Heart Failure medications
-
Lipid-Lowering medications